SCHEDULE 13D/A - Kymera Therapeutics, Inc. (0001815442) (Subject)
EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231Type: SCHEDULE 13D/ASIC: 6282 Investment Advice(CF Office: 02 Finance) EIN.: 812992166 | State of
EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231Type: SCHEDULE 13D/ASIC: 6282 Investment Advice(CF Office: 02 Finance)
EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91636 | Film No.: 261130899SIC: 2836 Biological Products, (No Diagnostic Substances)(CF Office: 03 Life Sciences)
Fuente original: SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1815442/000092189526001687/0000921895-26-001687-index.htm)
Esta información no constituye asesoramiento de inversión. Consulte con un profesional antes de tomar decisiones financieras.